The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Open accessThe DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues. We also discuss the emerging clinical data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 induces IL-6 and G-CSF, cytokines that promote myeloid-driven innate inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Gaffen et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways
Kim, J. S., Sklarz, T., Banks, L. B., Gohil, M., Waickman, A. T., Skuli, N., Krock, B. L., Luo, C. T., Hu, W., Pollizzi, K. N., et al. (2013) · Nature Immunology · doi:10.1038/ni.2607 · Cited by 85
RetractedMosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Self-citationHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Self-citationVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Research works printed but not linked: 1
- Ghoreschi K Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling Nature 467 967 971 20962846 PMC3108066 · DOI · Paper page
Cited by
Items 401–500 of 1,000
Chuang, H., Tsai, C., Hsueh, C., & Tan, T. (2018) · Science Advances · doi:10.1126/sciadv.aat5401 · Cited by 58
Wu, M.-Y., Yu, C., Yang, S., & Chi, C. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.07.103 · Cited by 58
Li, J., Ritelli, M., Ma, C. S., Rao, G., Habib, T., Corvilain, E., Bougarn, S., Cypowyj, S., Grodecká, L., Lévy, R., et al. (2019) · Science Immunology · doi:10.1126/sciimmunol.aax7965 · Cited by 58
Kashani, A., & Schwartz, D. A. (2019) · PubMed · Cited by 58
Sánchez-Rodríguez, G., & Puig, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210305 · Cited by 58
“Th17 cells are the best-known producers of IL-17A and IL-17F, and IL-23 is particularly important in maintaining their differentiation state [5].”
BackgroundRho Kinases in Autoimmune Diseases
Pernis, A. B., Ricker, E., Weng, C.-H., Rozo, C., & Yi, W. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-022120 · Cited by 50
Huynh, J., Scholz, G. M., Aw, J., Kwa, M. Q., Achuthan, A. A., Hamilton, J. A., & Reynolds, E. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501263 · Cited by 57
“Th17 cells are important mediators of host defense against bacteria, particularly bacteria that colonize mucosal surfaces (47, 48).”
Kong, B. S., Kim, Y., Kim, G. Y., Hyun, J., Kim, S., Jeong, A., & Kim, H. J. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0961-z · Cited by 57
“IL-23, produced by myeloid cells, is one of the cytokines that is essential for Th17 differentiation [38], and Th17 is associated with NMOSD relapse [39].”
BackgroundSatb1 regulates the effector program of encephalitogenic tissue Th17 cells in chronic inflammation
Yasuda, K., Kitagawa, Y., Kawakami, R., Isaka, Y., Watanabe, H., Kondoh, G., Kohwi-shigematsu, T., Sakaguchi, S., & Hirota, K. (2019) · Nature Communications · doi:10.1038/s41467-019-08404-w · Cited by 57
Benschop, R. J., Chow, C.-K., Tian, Y., Nelson, J., Barmettler, B., Atwell, S., Clawson, D., Chai, Q., Jones, B., Fitchett, J., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1624463 · Cited by 52
“In recent years, multiple studies have established the pathogenic involvement of Th17 cells and its cytokine IL-17 in autoimmune diseases, including psoriasis, psoriatic arthritis, RA, ankylosing spondylitis, and multiple sclerosis.(15,16) Both IL-17 and its receptor have been targeted by an array of FDA-approved ther…”
BackgroundCCAAT/Enhancer-binding protein β promotes pathogenesis of EAE
Simpson-Abelson, M. R., Hernández-Mir, G., Childs, E. E., Cruz, J. A., Poholek, A. C., Chattopadhyay, A., Gaffen, S. L., & McGeachy, M. J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.01.005 · Cited by 56
Self-citationAarts, P., Dudink, K., Vossen, A. R. J. V., van Straalen, K. R., Ardon, C. B., Prens, E. P., & van der Zee, H. H. (2021) · Drugs · doi:10.1007/s40265-021-01566-2 · Cited by 56
Reid, W. D. K., Close, A. J., Humphrey, S., Chaloner, G. L., Lacharme‐Lora, L., Rothwell, L., Kaiser, P., Williams, N. J., Humphrey, T. J., Wigley, P., et al. (2016) · Royal Society Open Science · doi:10.1098/rsos.150541 · Cited by 57
“The role of the anti-inflammatory TGF-β in regulating Th17 cell differentiation is complex because there appears to be differences in the relative importance of TGF-β in the Th17 response depending on the system being studied [46,48].”
BackgroundRole of Infections in the Pathogenesis of Rheumatoid Arthritis: Focus on Mycobacteria
Bo, M., Jasemi, S., Uras, G., Erre, G. L., Passiu, G., & Sechi, L. A. (2020) · Microorganisms · doi:10.3390/microorganisms8101459 · Cited by 56
“The secretion of IL-17A cytokines, by Th17 cells, activates a number of pathways such as Fibroblast-like synoviocytes (FLS), maturation and function of osteoclasts, activation of neutrophils, macrophages and B cells [40,41].”
BackgroundLiu, T., Dai, W., Li, C. R., Liu, F., Chen, Y., Weng, D., & Chen, J. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00868 · Cited by 56
Habash, T., Saleh, A. J., Chowdhury, S. R., Smith, D. R., & Fernyhough, P. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.08.016 · Cited by 55
“It contributes to the pathogenesis of inflammatory diseases by amplifying the effector immune response that increases tissue damage (Gaffen, 2011; Gaffen et al., 2014; Langrish, et al., 2005).”
BackgroundImmunotopographical Differences of Human Skin
Béke, G., Dajnoki, Z., Kapitány, A., Gáspár, K., Medgyesi, B., Póliska, S., Hendrik, Z., Péter, Z., Törőcsik, D., Bíró, T., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00424 · Cited by 55
Morelli, M., Scarponi, C., Mercurio, L., Facchiano, F., Pallotta, S., Madonna, S., Girolomoni, G., & Albanesi, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/7897263 · Cited by 55
“This dichotomy could depend by the fact that ERK1/2 activation by IFN-γ or IL-22 is mediated by JAK, whereas TNF-αdriven phosphorylation of ERK1/2 is downstream to TRAF2/TRADD [12].”
BackgroundInfluentialZhang, J., Zhou, R., Deng, L., Cao, G., Zhang, Y., Xu, H., Hou, J., Ju, S., & Yang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112948 · Cited by 55
The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives
Łyko, M., Ryguła, A., Kowalski, M., Karska, J., & Jankowska‐Konsur, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042440 · Cited by 54
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3
Zhang, C.-J., Wang, C., Jiang, M., Gu, C., Xiao, J., Chen, X., Martin, B. N., Tang, F., Yamamoto, E. A., Xian, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04974-3 · Cited by 55
Chen, J., He, R.-R., Sun, W., Gao, R., Peng, Q., Zhu, L., Du, Y., Ma, X., Guo, X., Zhang, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15564-7 · Cited by 54
Kabwe, M., Dashper, S. G., Bachrach, G., & Tucci, J. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab017 · Cited by 55
Sca‐1 + cardiac fibroblasts promote development of heart failure
Chen, G., Bracamonte‐Baran, W., Diny, N. L., Hou, X., Talor, M. V., Fu, K., Liu, Y., Davogustto, G., Vasquez, H., Taegtmeyer, H., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847583 · Cited by 53
The Th17/IL-17 Axis and Host Defense Against Fungal Infections
Tangye, S. G., & Puel, A. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.015 · Cited by 54
“Interleukin (IL)-17A, also named IL-17, belongs to the IL-17 family of cytokines, which includes IL-17B, IL-17C, IL-17D, IL-17E (also called IL-25) and IL-17F 13 .”
The role of salt for immune cell function and disease
Willebrand, R., & Kleinewietfeld, M. (2018) · Immunology · doi:10.1111/imm.12915 · Cited by 54
“It has previously been shown that IL-23 augments the pathogenicity of TH17 cells (35, 36).”
BackgroundHuman neutrophils activated via TLR8 promote Th17 polarization through IL-23
Tamassia, N., Arruda-Silva, F., Wright, H. L., Moots, R. J., Gardiman, E., Bianchetto-Aguilera, F. M., Gasperini, S., Capone, M., Maggi, L., Annunziato, F., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.ma0818-308r · Cited by 53
Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients
Sun, J.-K., Zhang, W., Chen, W., Wang, X., & Mu, X. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2799 · Cited by 53
Role of interleukin-23/interleukin-17 axis in T-cell-mediated actions in hypertension
Higaki, A., Mahmoud, A., Paradis, P., & Schiffrin, E. L. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa257 · Cited by 53
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 53
“Accumulating evidence indicates that T helper 17 (TH17) cells, which produce IL17 and IL22, can promote tumor development and progression in the gastrointestinal tract (Chae et al. 2010; Gaffen et al. 2014; Grivennikov et al. 2012).”
BackgroundZhang, J., Li, Q., Zou, Y.-R., Wu, S., Lu, X., Li, G., & Wang, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107433 · Cited by 53
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology
Lorè, N. I., Bragonzi, A., & Cigana, C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.009 · Cited by 52
“Th17 cells, a specific subset of CD4 effector cells [12,13], are commonly recognized as the major cellular source of IL-17A in several organs, including the airways [14,15].”
BackgroundInfluentialDuffield, A. S., Ascierto, M. L., Anders, R. A., Taube, J. M., Meeker, A. K., Chen, S., McMiller, T. L., Phillips, N. A., Xu, H., Ogurtsova, A., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017007260 · Cited by 53
Chenuet, P., Fauconnier, L., Madouri, F., Marchiol, T., Rouxel, N., Ledru, A., Mauny, P., Lory, R., Uttenhove, C., Snick, J. V., et al. (2017) · Clinical Science · doi:10.1042/cs20171034 · Cited by 52
Torshizi, A. D., & Wang, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.015 · Cited by 52
Conway, R. P., O’Neill, L., McCarthy, G., Murphy, C. C., Fabre, A., Kennedy, S., Veale, D. J., Wade, S. M., Fearon, U., & Molloy, E. S. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213488 · Cited by 53
Zhou, L., Adrianto, I., Wang, J., Wu, X., Datta, I., & Mi, Q. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00384 · Cited by 52
“RORγt and interleukin-23 receptor (IL-23R) are ubiquitously expressed in both adaptive and innate IL17-producing immune cells including NKT cells (Gaffen et al., 2014).”
BackgroundFernando, R., Caldera, O., & Smith, T. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114244118 · Cited by 52
FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes
Yang, W., He, R., Qu, H., Lian, W., Xue, Y., Wang, T., Lin, W., Zhu, P., Xia, M., Lai, L., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00973-7 · Cited by 52
“Immunological and genetic studies have identified the IL-23/IL-17 axis as a key driver of psoriasis pathogenesis [4, 30].”
BackgroundThe Role of IL-23/Th17 Pathway in Patients with Primary Immune Thrombocytopenia
Ye, X., Zhang, L., Wang, H., Chen, Y., Zhang, W., Zhu, R., Fang, C., Deng, A., & Qian, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117704 · Cited by 51
“) amplification of its own signal through the up-regulation of IL-23R expression[41].”
BackgroundThe Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells
Lochner, M., Wang, Z., & Sparwasser, T. D. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.013 · Cited by 53
Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
Little, A. J., & Vesely, M. D. (2020) · PubMed Central · Cited by 51
Advances in understanding of Netherton syndrome and therapeutic implications
Petrova, E., & Hovnanian, A. (2020) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2020.1857724 · Cited by 51
Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Meehan, E. V., & Wang, K. (2022) · Genes · doi:10.3390/genes13091643 · Cited by 51
“TGFβ and IL-6 have been predominantly implicated in Th17 differentiation in murine cells, whereas IL-1β has been identified as an important cytokine in human Th17 differentiation [36,37,56].”
BackgroundResultInfluentialStachyose modulates gut microbiota and alleviates DSS-induced ulcerative colitis in mice
Wang, C., Bai, J., Wang, B., Yu, L., Tian, F., Zhao, J., Zhang, H., Suo, H., Chen, W., & Zhai, Q. (2023) · Food Science and Human Wellness · doi:10.1016/j.fshw.2023.03.041 · Cited by 50
Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria
Bohlen, J., Zhou, Q., Philippot, Q., Ogishi, M., Rinchai, D., Nieminen, T., Seyedpour, S., Parvaneh, N., Rezaei, N., Yazdanpanah, N., et al. (2023) · Cell · doi:10.1016/j.cell.2023.09.024 · Cited by 50
Herbert, F., Tchitchek, N., Bansal, D., Jacques, J., Pathak, S., Bécavin, C., Fesel, C., Dalko, E., Cazenave, P., Preda, C., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0731-6 · Cited by 50
“This hypothesis is based on the fact that IL-23 promotes the differentiation of Th17 cells, and contributes also to renal tissue injury [43].”
BackgroundKitada, S., Kayama, H., Okuzaki, D., Koga, R., Kobayashi, M., Arima, Y., Kumanogoh, A., Murakami, M., Ikawa, M., & Takeda, K. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161076 · Cited by 50
“Accumulating evidence has shown that the Th17 responses are tightly controlled by the innate immune cells (Gaffen et al., 2014).”
BackgroundInfluentialA Distinct Inhibitory Function for miR-18a in Th17 Cell Differentiation
Montoya, M. M., Maul, J., Singh, P. B., Pua, H. H., Dahlström, F., Wu, N., Huang, X., Ansel, K. M., & Baumjohann, D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700170 · Cited by 50
Li, M., Gao, J., Tang, Y., Liu, M., Wu, S., Qu, K., Long, X., Li, H., Liu, M., Liu, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00959 · Cited by 51
“, 2012) targeting IL-17A and brodalumab (Gaffen et al., 2014) targeting IL-17RA, both of which show no efficacy or even higher rates of adverse events in IBD patients.”
BackgroundResultAraos, P. A., Prado, C. E., Lozano, M., Figueroa, S. M., Espinoza, A., Berger, T., Mak, T. W., Jaisser, F., Pacheco, R., Michea, L., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002067 · Cited by 50
“In this context, IL-23 is a heterodimeric cytokine composed by p19 and p40 subunits, which are secreted by dendritic cells thereby activating the IL-23 receptor in lymphocytes to induce Th17 polarization/stabilization during chronic inflammation in adaptive immunity [25].”
BackgroundThe Role of NLRP3 Inflammasome in Pneumococcal Infections
Surabhi, S., Cuypers, F., Hammerschmidt, S., & Siemens, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614801 · Cited by 50
“Th17-derived IL-17A acts as an additional chemoattractant-stimulating agent (95, 96) and indirectly mediates neutrophilia in the infected organs (Figure 1) (97).”
BackgroundGut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He, Y., Huang, J., Li, Q., Xia, W., Zhang, C., Liu, Z., Xiao, J., Yi, Z., Deng, H., Xiao, Z., et al. (2022) · Cancers · doi:10.3390/cancers14215317 · Cited by 50
“Th17 cells primarily produce IL-17A (also known as IL-17), IL-17F, and IL-22, cytokines that play an important role in inflammation [58].”
BackgroundCheng, H., Nan, F., Ji, N., Ma, X., Zhang, J., Liang, H., Zhang, W., Nakatsukasa, H., Zhang, H., Jin, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62628-7 · Cited by 49
“Compared to TGF-β 1 +IL-6 induced Th17 cells, anti-IL-2 +TGF-β 1+IL-6 induced Th17 cells exhibited a high expression of genes associated with chronic in fl ammatory diseases, such as Il23r 48,49 , Bhlhe40 50 , S100a4 51 , and Cd24a 52 (Fig.”
Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice
Yamashita, M., Ukibe, K., Matsubara, Y., Hosoya, T., Sakai, F., Kon, S., Arima, Y., Murakami, M., Nakagawa, H., & Miyazaki, T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02596 · Cited by 49
“TGF-β induces ROR-γt expression through SMAD phosphorylation and induces IL-23R and IL-1R expression in naïve T cells, rendering them receptive to IL-23 and IL-1β.”
BackgroundInfluentialSamuels, J. S., Holland, L., López, M., Meyers, K. R., Cumbie, W. G., McClain, A., Ignatowicz, A. P., Nelson, D., & Shashidharamurthy, R. (2018) · Inflammation Research · doi:10.1007/s00011-018-1153-8 · Cited by 49
The IL-23p19/EBI3 heterodimeric cytokine termed IL-39 remains a theoretical cytokine in man
Bridgewood, C., Alase, A. A., Watad, ., Wittmann, M., Cuthbert, R., & McGonagle, D. (2019) · Inflammation Research · doi:10.1007/s00011-019-01235-x · Cited by 49
“IL-23 has been shown to be a key orchestrator of the psoriatic disease spectrum and therapeutic targeting has proved successful in this disease [2, 8].”
BackgroundContribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis
Durham, L. E., Kirkham, B. W., & Taams, L. S. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0529-9 · Cited by 49
An updated guide in the management of psoriasis for every practitioner
Timiș, T. L., Florian, I. A., Vesa, Ș. C., Mitrea, D. R., & Orăsan, R.-I. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14290 · Cited by 48
Li, B., He, S., Liu, R., Huang, L., Liu, G., Wang, R., Yang, Z., Liu, X., Leng, Y., Liu, D., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112121 · Cited by 48
IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
Li, H., & Tsokos, G. C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08823-4 · Cited by 48
“Accordingly, the circulating IL-23 and IL-17 levels are elevated in SLE patients and correlate positively with disease severity [59, 70, 177–180].”
BackgroundResultInfluentialPreclinical and clinical characterization of the RORγt inhibitor JNJ-61803534
Xue, X., Leon-Tabaldo, A. D., Luna-Roman, R., Castro, G., Albers, M., Schoetens, F., DePrimo, S. E., Devineni, D., Wilde, T. C., Goldberg, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90497-9 · Cited by 49
Sano, T., Kageyama, T., Fang, V., Kedmi, R., Martinez, C. S., Talbot, J., Chen, A., Cabrera, I., Gorshko, O., Kurakake, R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109608 · Cited by 49
Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease
Soderquest, K., Hertweck, A., Giambartolomei, C., Henderson, S. R., Mohamed, R., Goldberg, R., Perucha, E., Franke, L., Herrero, J., Plagnol, V., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006587 · Cited by 47
“In addition to this, it is now apparent that mucosal inflammation is also driven by IL-17, which is enhanced by IL-23 receptor signals in effector T cells [10].”
BackgroundAffandi, A. J., Silva‐Cardoso, S. C., García, S., Leijten, E. F. A., van Kempen, T. S., Marut, W., van Roon, J. A. G., & Radstake, T. R. D. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201747195 · Cited by 47
Laufer, J. M., & Legler, D. F. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mr1217-494r · Cited by 47
Psoriasis and uveitis: links and risks
Fotiadou, C., & Lazaridou, E. (2019) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s179182 · Cited by 47
“In the absence of IL23, Th-17 still develops, but their role is not pathogenic, on the contrary, it is homeostatic.(45) Th-17 expresses also other cytokines that have important role in autoimmunity such as IL-22, IL-6, IL-17F, IL-21, IFN-γ, granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis f…”
BackgroundNanocarriers for topical delivery in psoriasis
Singhvi, G., Hejmady, S., Rapalli, V. K., Dubey, S. K., & Dubey, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817776-1.00004-3 · Cited by 47
Lu, Y., Liu, H., Yang, K., Mao, Y., Meng, L., Yang, L., Ouyang, G., & Liu, W. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100182 · Cited by 47
“Segmented filamentous bacteria (SFB) can activate Th17 cells to release 1L-17 and 1L-22, and promote the secretion of β-defensin and mucus to protect the gastrointestinal mucosa (Gaffen et al., 2014).”
BackgroundRole of pro-inflammatory interleukins in osteoarthritis: a narrative review
Jrad, A. I. S., Trad, M., Bzeih, W., Hasbani, G. E., & Uthman, I. W. (2022) · Connective Tissue Research · doi:10.1080/03008207.2022.2157270 · Cited by 47
The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
Duarte-Silva, E., Meuth, S. G., & Peixoto, C. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1137635 · Cited by 46
Little, R. D., Jayawardana, T. C., Koentgen, S., Zhang, F., Connor, S. J., Boussioutas, A., Ward, M. G., Gibson, P. R., Sparrow, M., & Hold, G. L. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100006 · Cited by 46
Leonardi, L., Perna, C., Bernabei, I., Fiore, M., Ma, M., Frankovich, J., Tarani, L., & Spalice, A. (2024) · Children · doi:10.3390/children11091043 · Cited by 47
“Due to their cytokine profile and ability to recruit other immune cell types, they are highly pro-inflammatory and are involved in the induction of many autoimmune disorders [47,48].”
BackgroundTargeting persistently activated inflammatory microenvironment to promote chronic wound healing
Dai, Y., & Chen, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1708358 · Cited by 47
“…the generation of T Reg and inhibits Th17 cells, forming a self-limiting Among the pathological drivers of delayed or non-healing chronic wounds, sustained hyperactivation of the IL-23/IL-17 axis is recognized as a major contributor to maintaining the pro-in fl ammatory microenvironment (264, 265).”
AbuHilal, M., Walsh, S. R., & Shear, N. H. (2016) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475416651605 · Cited by 46
“CD4+ T cells are divided into several subtypes, including Th1, Th2, and Th17 cells, regulatory T cells, and T follicular helper cells, on the basis of different cytokines and/or chemokines they synthesize and express.1,5,6 IL-17 molecules are produced predominantly by Th17 T cells but can also be secreted by other cel…”
BackgroundInfluentialKim, J., Tomalin, L. E., Lee, J., Fitz, L. J., Berstein, G., da Rosa, J. C., Garcet, S., Lowes, M. A., Valdez, H., Wolk, R. A., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.08.040 · Cited by 46
“Pathways used for analysis were curated from published papers (Gaffen et al., 2014, Kim and Krueger, 2017, Tian et al., 2012, Witte et al., 2015), Molecular Signature Database (http://www. broadinstitute.org/gsea/msigdb) and Gene Ontology Database (http://wiki.geneontology.org).”
Wang, J., Sekai, M., Matsui, T., Fujii, Y., Matsumoto, M., Takeuchi, O., Minato, N., & Hamazaki, Y. (2018) · International Immunology · doi:10.1093/intimm/dxy073 · Cited by 46
“IL-23 is produced by DCs under various pathogenic conditions involving T h 17 cell activation (52), and in the thymus, IL-23 is produced by CD103 + cDCs following γ -ray irradiation to stimulate lymphoid tissue inducer cells and promote TEC recovery (44).”
Acute and Chronic Inflammation Induces Disease Pathogenesis
Ptaschinski, C., & Lukacs, N. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00002-x · Cited by 47
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection
Tosello, J., Furlan, C. L. A., Vernengo, F. F., Rodríguez, C., Ramello, M. C., Vesely, M. C. A., Serrán, M. G., Núñez, N. G., Richer, W., Piaggio, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02347 · Cited by 47
IκBζ is a key player in the antipsoriatic effects of secukinumab
Bertelsen, T., Ljungberg, C., Litman, T., Huppertz, C., Hennze, R., Rønholt, K., Iversen, L., & Johansen, C. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.029 · Cited by 46
Wang, D., & Lei, L. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13962 · Cited by 46
Osteoimmunology in periodontitis; a paradigm for Th17/IL-17 inflammatory bone loss
Ikeuchi, T., & Moutsopoulos, N. M. (2022) · Bone · doi:10.1016/j.bone.2022.116500 · Cited by 46
He, Z., Wang, F., Ma, J., Sen, S., Zhang, J., Gwack, Y., Zhou, Y., & Sun, Z. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600548 · Cited by 46
The regulatory mechanism and potential application of IL-23 in autoimmune diseases
Xiong, D.-K., Shi, X., Han, M., Zhang, X., Wu, N.-N., Sheng, X.-Y., & Wang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.982238 · Cited by 45
“IL-12Rβ1 subunit is mainly expressed on T cells, monocytes/macrophages, natural killer (NK) T cells, and DC cells (Pahan and Jana, 2009), whereas IL-23 subunit is expressed on specific T cells (Gaffen et al., 2014) and minor expression on B cells and lymphoid cells (Chognard et al.”
BackgroundConnor, C. H., Zucoloto, A. Z., Munnoch, J., Yu, I.-L., Corander, J., Hoskisson, P. A., McDonald, B., & McNally, A. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002329 · Cited by 45
The foreign body response: emerging cell types and considerations for targeted therapeutics
Yang, B., Rutkowski, N., & Elisseeff, J. H. (2023) · Biomaterials Science · doi:10.1039/d3bm00629h · Cited by 46
Tian, K., Jing, D., Lan, J., Lv, M., & Wang, T. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1316 · Cited by 45
“40,41 Antimicrobial peptides (AMPs) are produced in response to IL ‐ 17 and IL ‐ 22, and these AMPs alter the gastrointestinal tract's microbiota makeup.”
BackgroundRetinoic acid suppresses IL‐17 production and pathogenic activity of γδ T cells in CNS autoimmunity
Raverdeau, M., Breen, C. J., Misiak, A., & Mills, K. H. G. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.39 · Cited by 45
Zhao, G., Liu, Y., Yi, X., Wang, Y., Qiao, S., Li, Z., Ni, J., & Song, Z. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.02.017 · Cited by 45
“It is indispensable to polarize Th17 cell differentiation that STAT3-activated cytokines IL-6, IL-21 and IL-23, togetherwith IL-1 and TGF-β [2].”
BackgroundDendritic cells in systemic sclerosis: Advances from human and mice studies
Affandi, A. J., Carvalheiro, T., Radstake, T. R. D. J., & Marut, W. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.003 · Cited by 45
Sen, S., Wang, F., Zhang, J., He, Z., Ma, J., Gwack, Y., Xu, J., & Sun, Z. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717789115 · Cited by 45
“Multiple transcription factors have been shown to regulate the development of IL-17 and Foxp3 cells (29).”
BackgroundCao, W., Wang, X., Chen, T., Xu, W., Feng, F., Zhao, S., Wang, Z., Hu, Y., & Xie, B. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6144 · Cited by 45
Fang, S., Huang, Y., Liu, X., Zhong, S., Wang, N., Zhao, B., Li, Y., Sun, J. P., Wang, Y., Zhang, S., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24008 · Cited by 45
Patient preference for biologic treatments of psoriasis in Japan
Tada, Y., Ishii, K., Kimura, J., Hanada, K., & Kawaguchi, I. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14870 · Cited by 45
Reis, J., Vender, R. B., & Torres, T. R. (2019) · BioDrugs · doi:10.1007/s40259-019-00361-6 · Cited by 45
CD109 Restrains Activation of Cutaneous IL-17-Producing γδ T Cells by Commensal Microbiota
Zhang, H., Carnevale, G., Polese, B., Simard, M., Thurairajah, B., Khan, N., Gentile, M. E., Fontès, G., Vinh, D. C., Pouliot, R., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.003 · Cited by 45
Th17 Cells in Viral Infections—Friend or Foe?
Paiva, I. A., Badolato-Corrêa, J., Familiar-Macedo, D., & de‐Oliveira‐Pinto, L. M. (2021) · Cells · doi:10.3390/cells10051159 · Cited by 46
Evolution of developmental and comparative immunology in poultry: The regulators and the regulated
Lu, M., Lee, Y., & Lillehoj, H. S. (2022) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2022.104525 · Cited by 45
Yoshikawa, F. S. Y., Yabe, R., Iwakura, Y., de Almeida, S. R., & Saijo, S. (2016) · Innate Immunity · doi:10.1177/1753425916645392 · Cited by 45
Yang, W., Zhou, G., Yu, T., Chen, L., Lin, Y., Guo, Y., Cong, Y., & Liu, Z. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.009 · Cited by 45
Metadata
- Authors
- Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Cua, Daniel J.
- Venue
- Nature reviews. Immunology
- Published
- 2014-08-22
- Volume
- 14
- Issue
- 9
- Pages
- 585-600
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4281037
- OpenAlex
- W2064645845
- Cited by
- 1,585
- References
- 187
- Citations by year
- 2026: 119 · 2025: 104 · 2024: 111 · 2023: 126 · 2022: 118 · 2021: 159 · 2020: 162 · 2019: 131 · 2018: 153 · 2017: 155 · 2016: 129 · 2015: 111 · 2014: 6
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI107825, AI107825)
- National Institute of Dental and Craniofacial Research (R01DE022550, R01DE023815, DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-23, IL-17, Th17 cells, T cell lineage commitment, transcriptional regulation, IL-17 signaling, mesenchyme, immune-mediated inflammatory diseases, therapeutic antibodies
- MeSH terms
- Antibodies, Autoimmune Diseases, Epithelial Cells, Humans, Transcription, Genetic, Signal Transduction, Cytokines, Tight Junctions, Interleukin-17, Receptors, Interleukin-17, Interleukin-23, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.